Market Scenario
In 2017, the global market size of circulating tumor cell (CTC) reached a valuation of USD 9,393.1 Mn. The market is projected to surpass a valuation of USD 28,300 Mn by the end of 2023, reflecting a healthy growth rate. The prevalence rate of CTC has gone up in recent years. The mechanism of CTC is responsible for a vast majority of deaths caused by cancer. Significant progress has been made in developing effective CTC diagnostics and treatment, though, survival rates remain moderate. Circulating tumor cells can be associated with different types of cancer prognosis including breast cancer, prostate cancer, and gastric cancer among others. Healthcare companies continue to focus on developing solutions that enable accurate and quick detection of CTC. The diagnosis and analysis of CTCs can help in early cancer detection and determine appropriate treatments tailored for specific cancer types.

Global Circulating Tumor Cell Market – Segments
MRFR has segmented its analysis into four Key dynamics for an easy grasp;
By Applications : Clinical, Research, and Drug Development among others.
By Technologies : CTC Enrichment, CTC Detection, and Combined Enrichment and Separation of CTC (CTC analysis) among others.
By End-Users : Hospital & Clinics, Research & Academic Institutes, and Diagnostic Centers among others.
By Regions : APAC, North America, Europe, and the Rest-of-the-World.
Key Players:
Some of the eminent leaders of the market include Greiner Bio-One International GmbH, Ikonisys Inc., Thermo Fisher Scientific, STEMCELL Technologies, SRI International, Miltenyi Biotec, QIAGEN Hannover (QIAGEN), Menarini Silicon Biosystems, F. Hoffmann-La Roche Ltd, Fluxion Biosciences, Inc., NanoString Technologies, Inc, GE Healthcare, Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation), ApoCell, Celltraffix Inc., and Epic Lifesciences.
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/581 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]